Syneos Health Announces Partnership with Fosun Pharma USA to Launch Serplulimab
11 janv. 2023 07h10 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 11, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced a strategic partnership with...
Syneos Health Reports Third Quarter 2022 Results
04 nov. 2022 06h10 HE
|
Syneos Health, Inc.
Revenue for the third quarter of $1,336.2 million decreased 0.9% on a reported basis and increased 2.2% on a constant currency basis year-over-year.Clinical Solutions net new business awards and...
Syneos Health Adds HUB Patient Suite to Deployment Solutions Business
27 oct. 2022 07h30 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced it is introducing a dedicated...
Syneos Health Acquires RxDataScience
06 oct. 2021 08h16 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the acquisition of...
Syneos Health Acquires StudyKIK
14 sept. 2021 17h30 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the acquisition of StudyKIK, a...